Birth Control Pills And Cancer Risk: What IARC’s Group 1 Classification Really Means

The International Agency for Research on Cancer, a cancer research agency under the World Health Organization, has classified combined estrogen-progestogen oral contraceptives as a Group 1 carcinogen because scientific evidence shows they can increase the risk of certain cancers under specific conditions. This classification applies globally through IARC’s scientific cancer hazard evaluations, but it does not mean birth control pills carry the same real-life danger as tobacco, alcohol, or asbestos. It means there is strong evidence of a cancer link, not that the chance of developing cancer is equally high.

What Group 1 Means

A Group 1 classification is often misunderstood. It does not rank how risky something is in everyday life. Instead, it shows that researchers have enough evidence to say an agent is capable of causing cancer. This is why oral contraceptives can appear in the same category as tobacco and asbestos, even though the actual risk level is very different.

The Cancer Risk Side

Studies have linked combined oral contraceptives with a small increase in breast cancer risk and a possible increase in cervical cancer risk, especially during current or recent use. The breast cancer risk generally begins to fall after stopping the pill and returns close to normal after about 10 years.

The Protective Side

The same pills are also linked with lower risks of ovarian and endometrial cancers, with protection becoming stronger the longer they are used. Evidence also shows reduced colorectal cancer risk among users in several studies, although some reviews note that the colorectal link is less consistent than ovarian and endometrial protection.

Why Personal Medical Advice Matters

The key point is balance. For many people, the long-term protection against ovarian and uterine cancers may outweigh the temporary increase in some other cancer risks. Birth control pills are also used to manage conditions such as endometriosis, PCOS, painful periods, and heavy bleeding.

The best decision depends on personal medical history, family cancer history, age, lifestyle, and individual risk factors. Anyone considering or currently using hormonal contraception should discuss the benefits and risks with a qualified healthcare professional instead of relying only on a cancer category label.